E2F1 Expression is Related with the Poor Survival of Lymph Node-positive Breast Cancer Patients Treated with Fluorouracil, Doxorubicin and Cyclophosphamide
- 1 November 2003
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 82 (1), 11-16
- https://doi.org/10.1023/b:brea.0000003843.53726.63
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor developmentOncogene, 1998
- Cancer Cell CyclesScience, 1996
- E2F-1 Functions in Mice to Promote Apoptosis and Suppress ProliferationCell, 1996
- Tumor Induction and Tissue Atrophy in Mice Lacking E2F-1Cell, 1996
- The retinoblastoma protein and cell cycle controlCell, 1995
- Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis.Proceedings of the National Academy of Sciences, 1994
- G1 phase progression: Cycling on cueCell, 1994
- p53 and E2F-1 cooperate to mediate apoptosis.Proceedings of the National Academy of Sciences, 1994
- Expression of transcription factor E2F1 induces quiescent cells to enter S phaseNature, 1993
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991